# EDGAR Filing Document

**Accession Number:** 0001086888
**File Stem:** 0001086888-26-000045
**Filing Date:** 2026-5
**Character Count:** 65082
**Document Hash:** 4f45baa288dee5de69b8c7f558c302a5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001086888-26-000045.hdr.sgml**: 20260513

**ACCESSION NUMBER**: 0001086888-26-000045

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 5

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260513

**DATE AS OF CHANGE**: 20260513

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MANULIFE FINANCIAL CORP
- **CENTRAL INDEX KEY:** 0001086888
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 889897526
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14942
- **FILM NUMBER:** 26974510

**BUSINESS ADDRESS:**
- **STREET 1:** 200 BLOOR ST EAST, NT-10
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M4W1E5
- **BUSINESS PHONE:** 416-926-3000

**MAIL ADDRESS:**
- **STREET 1:** 200 BLOOR ST EAST, NT-10
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M4W1E5

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**Form 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER** 

**PURSUANT TO RULE 13a-16 OR 15d-16** 

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the month of May 2026**

**Commission File Number: 1-14942**

**MANULIFE FINANCIAL CORPORATION**

**(Translation of registrant's name into English)**

**200 Bloor Street East**

**North Tower 10**

**Toronto, Ontario, Canada M4W 1E5**

**(416) 926-3000**

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-

F or Form 40-F.

Form 20-F ◻ Form 40-F ☒

**DOCUMENTS FILED AS PART OF THIS FORM 6-K**

The following documents, filed as exhibits to this Form 6-K, are incorporated by reference as

part of this Form 6-K:

---

| | |
|:---|:---|
| <u>Exhibit</u> | <u>Description of Exhibit</u> |
| 99.1 | News release - first quarter results dated May 13, 2026 |
| 99.2 | News release - quarterly dividend announcement dated May 13, 2026 |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly

caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | MANULIFE FINANCIAL CORPORATION | MANULIFE FINANCIAL CORPORATION |
|  | By: | */s/ Eddy Mezzetta* |
|  | Name: | Eddy Mezzetta |
|  | Title: | Vice President and Chief Counsel, Corporate Law |
| Date: May 13, 2026 |  |  |

---

## Exhibit 99.1

![picture2.jpg](picture2.jpg)

**Manulife Reports** 

**First Quarter 2026 Results**

***TSX/NYSE/PSE: MFC SEHK: 945*** *C$ unless otherwise stated*

**TORONTO, ON** – May 13, 2026 – Manulife Financial Corporation ("Manulife" or the "Company") reported its first

quarter results for the period ended March 31, 2026, delivering double-digit core EPS and new business CSM

growth year over year.

**Key highlights for the first quarter of 2026 ("1Q26") include:**

• Core earnings<sup>1</sup> of $1.8 billion, up 8% on a CER basis<sup>2</sup> compared with the first quarter of 2025 ("1Q25")

• Net income attributed to shareholders of $1.1 billion, up $0.7 billion from 1Q25

• Core EPS<sup>3</sup>of $1.06, up 11%<sup>2</sup> from 1Q25. EPS of $0.65, up 178%<sup>2</sup> from 1Q25

• Core ROE<sup>3</sup> of 16.5% and ROE of 10.1%

• LICAT ratio<sup>4</sup> of 136%

• APE sales up 7%<sup>5</sup>, new business CSM up 16%<sup>2</sup> and new business value ("NBV") up 7%<sup>5</sup> from 1Q25

• Global Wealth and Asset Management ("Global WAM") net outflows<sup>5</sup> of $4.4 billion, compared with $0.5 billion of

net inflows in 1Q25

"We delivered a solid first quarter, executing our strategy and demonstrating the strength of our diversified

portfolio. We generated double-digit growth in core EPS, and new business momentum continued to build,

driving double-digit growth in new business CSM across all three insurance segments, despite macroeconomic

uncertainty.

"Asia achieved another strong quarter, with 22% growth in core earnings and 15% growth in new business

value, reflecting robust contributions from key markets in the region. In Global WAM, core EBITDA margin<sup>3</sup>

improved year over year, notwithstanding the impact of the eMPF transition, and Manulife \| Comvest

contributed positively to margin, core earnings and net inflows.

"We made sustained progress against our strategic priorities — expanding our health proposition with new

partnerships in Asia and Canada, advancing Global WAM through our partnership with L&G<sup>6</sup>, and further

differentiating our U.S. product offerings. We scaled AI delivery across our global footprint to enhance

distributor experience and improve productivity and efficiency. We remain well positioned to deliver our targets

and capture growth, generating sustainable value for shareholders."<sup>7</sup>

***— Phil Witherington, Manulife President & Chief Executive Officer***

"Our balance sheet and financial performance demonstrated resilience during a volatile quarter. Excess capital

remained strong, our financial leverage ratio improved, and book value per common share increased to an all-

time high<sup>8</sup>. We continued to deploy capital in a disciplined manner, returning $1.2 billion to shareholders

through dividends and share buybacks, and on the acquisition of Schroders Indonesia. Core ROE was 16.5%

for the quarter, an increase of 90 basis points compared with 1Q25, and our expense efficiency ratio of 46%<sup>3</sup>

remained in-line year over year, while continuing strategic investments in AI and reflecting the impact of the

Comvest acquisition in Global WAM."

***— Colin Simpson, Manulife Chief Financial Officer***

**<u>Results at a Glance</u>**

---

| | | | |
|:---|:---|:---|:---|
| ($ millions, unless otherwise stated) | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** |
| ($ millions, unless otherwise stated) | **1Q26** | 1Q25 | Change<sup>2,5</sup> |
| Net income attributed to shareholders  | **$1147** | $485 | 149% |
| Core earnings | **$1836** | $1767 | 8% |
| EPS ($) | **$0.65** | $0.25 | 178% |
| Core EPS ($) | **$1.06** | $0.99 | 11% |
| ROE | **10.1%** | 3.9% | 6.2 pps |
| Core ROE | **16.5%** | 15.6% | 0.9 pps |
| Book value per common share ($) | **$26.30** | $25.88 | 2% |
| Adjusted BV per common share ($)<sup>3</sup> | **$39.01** | $36.66 | 6% |
| Financial leverage ratio (%)<sup>3</sup> | **22.5%** | 23.9% | (1.4) pps |
| APE sales | **$2821** | $2689 | 7% |
| New business CSM | **$1019** | $907 | 16% |
| NBV | **$944** | $907 | 7% |
| Global WAM net flows ($ billions) | **$(4.4)** | $0.5 | -% |

---

**<u>Results by Segment</u>**

---

| | | | |
|:---|:---|:---|:---|
| ($ millions, unless otherwise stated) | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** |
| ($ millions, unless otherwise stated) | **1Q26** | 1Q25 | Change<sup>5</sup> |
| **Asia (US$)** |  |  |  |
| Net income attributed to shareholders | **$433** | $435 | 2% |
| Core earnings | **598** | 492 | 22% |
| APE sales | **1599** | 1412 | 11% |
| New business CSM | **585** | 498 | 15% |
| NBV | **533** | 457 | 15% |
| **Canada** |  |  |  |
| Net income attributed to shareholders  | **$238** | $222 | 7% |
| Core earnings | **352** | 374 | (6)% |
| APE sales | **416** | 491 | (15)% |
| New business CSM | **103** | 91 | 13% |
| NBV | **152** | 180 | (16)% |
| **U.S. (US$)** |  |  |  |
| Net income attributed to shareholders  | **$101** | $(397) | -% |
| Core earnings | **241** | 251 | (4)% |
| APE sales | **155** | 120 | 29% |
| New business CSM | **83** | 70 | 19% |
| NBV | **44** | 48 | (8)% |
| **Global WAM** |  |  |  |
| Net income attributed to shareholders  | **$403** | $443 | (5)% |
| Core earnings | **448** | 454 | 2% |
| Gross flows ($ billions)<sup>5</sup> | **56.0** | 50.3 | 15% |
| Average AUMA ($ billions)<sup>5</sup> | **1118** | 1041 | 11% |
| Core EBITDA margin (%) | **29.0%** | 28.4% | 60 bps |

---

**<u>Strategic Highlights</u>**

**We are executing to expand our diversified portfolio and further strengthen distribution capabilities and** 

**product leadership**

In Asia, we received recognition as Asia's Best Insurance Provider for Wealth Management at the 2026

Euromoney Private Banking Awards, a leading benchmark in the private banking and wealth management

industry. This acknowledgement reflects our strong growth momentum, innovative product suite for high-net-worth

("HNW") customer segments, value-added service, international capabilities, and trusted relationships with our

distribution partners across all HNW channels.

In Global WAM, we completed the acquisition of PT Schroder Investment Management Indonesia ("Schroders

Indonesia") with $3.5 billion of assets under management ("AUM") as of March 31, 2026. The acquisition

strengthens our position as the largest asset manager in Indonesia<sup>9</sup> and enables us to deliver enhanced value to

our clients and stakeholders by leveraging the firm's local expertise and client relationships.

In addition, we entered into a strategic partnership with L&G<sup>6</sup> to enhance our distribution, investment management,

and product development capabilities. The partnership is intended to combine our global asset management

expertise and distribution platform with L&G's strengths as a global asset manager and distribution capabilities,

especially across Europe, bringing together complementary capabilities to expand access to differentiated

investment solutions across institutional, retirement, and retail channels.

In the U.S., we further differentiated our product portfolio through enhancements to our indexed and hybrid

indexed universal life offerings, better positioning us to address evolving income-protection and wealth-

accumulation needs and supporting our growth strategy. Furthermore, we reinforced our industry-leading large-

case underwriting capabilities by increasing auto-bind limits through reinsurer support, simplifying underwriting and

reducing friction for complex submissions.

**We are deploying AI globally to enhance distributor experience, drive efficiency, and deliver value**

We accelerated our momentum across our enterprise AI platform, establishing production-ready environments and

enabling initial scalable use cases, while leveraging new strategic partnerships with Akka<sup>10</sup> and Adaptive ML<sup>11</sup>. In

addition, our developers across the organization continued to adopt assisted and autonomous AI capabilities,

increasing their productivity by 30% while enabling reinvestment to support business growth and develop new

capabilities to serve our customers. Together, we expect these advancements will enhance our ability to deploy AI

at scale with speed, consistency, and in alignment with our Responsible AI Principles.

Building on the roll out of agent and advisor AI tools in a number of our Asia markets in 2025, we launched our

distributor AI tool in Vietnam to support faster access to product information, premium calculations and simplified

illustrations for customers. In Japan, we also enhanced our AI tool to provide a unified, always-available entry point

to information about our independent agents, including their affiliations, branch details, and product license

eligibility, enabling us to provide better and faster support to these agents.

In Global WAM, we introduced an AI-powered sales platform in U.S. Retail to better integrate data, enabling more

personalized advisor conversations and smarter sales deployment. This platform allows sales teams to prioritize

the most promising opportunities, driving an approximately 40% increase in meaningful advisor interactions and

supporting higher flows.

In the U.S., we continued to realize benefits from scaling GenAI investments in underwriting through the expansion

of our Quick Quote support tool, enabling us to automate nearly half of preliminary assessments, which

accelerated average turnaround time from days to minutes and enabled underwriters to focus on more complex

cases.

In Canada, we enhanced online claims processing for our Affinity health & dental business through AI-driven

document processing for the majority of manually processed claims, which improved processing speed and

accelerated payments to customers.

**We are advancing our health, wealth and longevity strategy while establishing new strategic partnerships** 

In Asia, we established an exclusive partnership with Guardant Health to offer the Shield™ Multi-Cancer Detection

test ("Shield MCD test")<sup>12</sup> to eligible customers in Hong Kong, Singapore, and the Philippines. The collaboration

makes us the first insurer in Asia to offer the Shield MCD test, broadening access to early cancer detection and

advancing our commitment to improving customer health outcomes and longevity.

In Canada, we partnered with Osara Health<sup>®</sup>, a global provider of evidence-based cancer support programs to

pilot the Cancer Coach™ program and offer eligible Group Benefits members structured and personalized support

for navigating the daily challenges that accompany a cancer diagnosis, treatment, and recovery.

We also advanced Manulife's commitment to longevity through a partnership with the National Institute on Ageing,

supporting the release of the Ageing in Canada Survey, one of Canada's most comprehensive annual snapshots of

aging, and building on our commitment to health, wealth and financial wellbeing.

In the U.S., we launched John Hancock Vitality PRO, a distributor-facing engagement platform designed to

support the promotion of John Hancock Vitality and to enhance producer loyalty. Early adoption continues to build,

reinforcing engagement in John Hancock Vitality and our mission to help customers live longer, healthier, better

lives.

**<u>Continued business growth drove core earnings higher</u>**<sup>13</sup>

**Core earnings of $1.8 billion in 1Q26, up 8% from 1Q25**

The increase in core earnings reflected strong business growth in Asia and Global WAM, the net positive impact of

2025 updates to actuarial methods and assumptions, and a net improvement in insurance experience, partially

offset by lower investment spreads in the U.S. and the impact of the eMPF transition in Hong Kong.

• Asia core earnings increased 22%, reflecting continued business growth and the net positive impact of 2025

updates to actuarial methods and assumptions, partially offset by less favourable insurance experience.

• Global WAM core earnings increased 2%, driven by higher net fee income from favourable market impacts

over the past 12 months, contribution from the Manulife \| Comvest business, and continued expense

discipline, partially offset by the impact of the eMPF transition in Hong Kong and lower performance fees.

• Canada core earnings decreased 6%, reflecting unfavourable insurance experience in Group Insurance in

1Q26, compared with favourable experience in 1Q25. The variance in insurance experience was largely driven

by higher long-term disability claims, along with higher expenses to support the growing business and

transformational investment to elevate customer experience in Group Insurance. This was partially offset by

business growth in the segment, the net positive impact of 2025 updates to actuarial methods and

assumptions, and a lower charge in the expected credit loss provision.

• U.S. core earnings decreased 4%, primarily driven by lower investment spreads, partially offset by favourable

net insurance experience in 1Q26 compared with unfavourable experience in 1Q25.

• Corporate and Other core earnings improved by $12 million, reflecting the non-recurrence of the 1Q25

provision for the California wildfires in our P&C reinsurance business, partially offset by lower investment

income and higher expenses from continued strategic investments in transformational efforts, including AI-

focused initiatives.

**Net Income attributed to shareholders of $1.1 billion in 1Q26, $0.7 billion higher compared with 1Q25**

The $0.7 billion increase in net income was primarily driven by a smaller net charge related to market experience

and core earnings growth. The net charge from market experience in 1Q26 reflected lower-than-expected returns

on public equity and lower-than-expected returns on alternative long-duration assets, mainly related to real estate,

timber, and private equity investments. The market experience in 1Q25 included a $0.7 billion realized loss related

to the RGA U.S. Reinsurance Transaction from the sale of debt instruments, which was offset by an associated

change in Other Comprehensive Income with a net neutral impact to book value.<sup>14</sup>

**<u>Insurance new business growth momentum continued, with a double-digit increase in new business CSM</u>**

**<u>across all segments</u>**

**APE sales, new business CSM and NBV increased 7%, 16%, and 7%, respectively, reflecting the strength** 

**of our diversified business portfolio** 

• Asia delivered strong growth in APE sales, new business CSM and NBV, with a year-over-year increase of

11%, 15% and 15%, respectively, driven by higher sales volumes and a more favourable business mix,

reflecting growth in Hong Kong, Japan and Singapore across all three new business metrics. NBV margin

improved modestly to 38.2%.<sup>5</sup>

• Canada APE sales and NBV decreased 15% and 16%, respectively, driven by lower Group Insurance sales,

partially offset by higher Individual Insurance sales. New business CSM increased 13%, reflecting the growth

in Individual Insurance from higher participating life insurance sales.

• In the U.S., APE sales and new business CSM increased 29% and 19%, respectively, reflecting increased

demand for our accumulation insurance products supported by recent product enhancements. NBV decreased

8%, primarily driven by product mix, partially offset by higher sales volumes.

**Global WAM net outflows of $4.4 billion in 1Q26, compared with net inflows of $0.5 billion in 1Q25**

• Retirement net outflows were $2.8 billion in 1Q26 compared with net outflows of $2.6 billion in 1Q25, driven by

higher member withdrawals reflecting higher account balances from market growth and higher retirement plan

redemptions in the U.S., partially offset by lower retirement plan redemptions in Canada.

• Retail net outflows were $5.8 billion in 1Q26 compared with net inflows of $0.5 billion in 1Q25, primarily driven

by higher net outflows in active mutual funds through third-party intermediaries in North America, including a

few large model redemptions in the U.S.

• Institutional Asset Management net inflows were $4.2 billion in 1Q26 compared with net inflows of $2.6 billion

in 1Q25, driven by net flows from the Manulife \| Comvest business, and higher net sales from money market

mandates in mainland China and from Manulife \| CQS products, partially offset by lower net flows in equity

mandates and lower deployments in private equity mandates.

**<u>New business growth continued to drive higher organic CSM and CSM balance</u>**

**CSM**<sup>15</sup> **was $25,589 million as at March 31, 2026**

CSM increased $620 million compared with December 31, 2025. Organic CSM movement contributed $650 million

of the increase, representing an 11% annualized growth in our CSM net of NCI balance<sup>16</sup>, primarily driven by the

impact of new business, interest accretion and net favourable insurance experience, partially offset by amortization

recognized in core earnings. Inorganic CSM movement was a decrease of $30 million, primarily driven by the

unfavourable impacts of equity market performance and interest rate movements, partially offset by the impacts of

changes in foreign currency exchange rates. Post-tax CSM net of NCI<sup>1</sup> was $21,255 million as at March 31, 2026.

<sup>(1)</sup> Core earnings and post-tax contractual service margin net of NCI ("post-tax CSM net of NCI") are non-GAAP financial measures. For more information on non-

GAAP and other financial measures, see "Non-GAAP and other financial measures" below and in our 1Q26 Management's Discussion and Analysis ("1Q26

MD&A").

<sup>(2)</sup> Percentage growth/declines in core earnings, diluted core earnings per common share ("core EPS"), diluted earnings (loss) per share ("EPS"), new business

contractual service margin net of NCI ("new business CSM"), and net income attributed to shareholders are stated on a constant exchange rate ("CER") basis

and are non-GAAP ratios.

<sup>(3)</sup> Core EPS, core ROE, core EBITDA margin, expense efficiency ratio, adjusted book value per common share ("adjusted BV per common share"), and financial

leverage ratio are non-GAAP ratios.

<sup>(4)</sup> Life Insurance Capital Adequacy Test ("LICAT") ratio of The Manufacturers Life Insurance Company ("MLI") as at March 31, 2026. LICAT ratio is disclosed under

the Office of the Superintendent of Financial Institutions ("OSFI's") Life Insurance Capital Adequacy Test Public Disclosure Requirements guideline.

<sup>(5)</sup> For more information on annualized premium equivalent ("APE") sales, new business value ("NBV"), net flows, gross flows, average asset under management

and administration ("average AUMA") and new business value margin ("NBV margin"), see "Non-GAAP and other financial measures" below. In this news

release, percentage growth/decline in APE sales, NBV, net flows, gross flows, and average AUMA are stated on a constant exchange rate basis.

<sup>(6)</sup> Legal & General Investment Management Limited and Legal and General Assurance Society, collectively referred to as "L&G".

<sup>(7)</sup> See "Caution regarding forward-looking statements" below.

<sup>(8)</sup> Under IFRS 17.

<sup>(9)</sup> Based on AUM as of February 2026.

<sup>(10)</sup> Akka provides a secure and scalable software foundation to build trusted AI-powered business applications.

<sup>(11)</sup> Adaptive ML provides a reinforcement-learning-powered engine to fine-tune, evaluate, and deploy open-source small language models (SLMs) for enterprise

applications.

<sup>(12)</sup> The Shield MCD test is intended to detect 10 cancers with a single blood draw, and is for export use only outside of the United States.

<sup>(13)</sup> See section A1 "Profitability" in our 1Q26 MD&A for more information on notable items attributable to core earnings and net income attributed to shareholders.

<sup>(14)</sup> The reinsurance transaction with the Reinsurance Group of America, Incorporated ("RGA U.S. Reinsurance Transaction") closed January 1, 2025.

<sup>(15)</sup> Net of non-controlling interests ("NCI").

<sup>(16)</sup> Percentage growth / decline in our CSM net of NCI balance from organic CSM movement is stated on a constant exchange rate basis and is a non-GAAP ratio.

This percentage is calculated as the annualized year-to-date change in organic CSM net of NCI divided by the December 31, 2025 CSM net of NCI balance.

**<u>Earnings Results Conference Call</u>**

Manulife will host a conference call and live webcast on its First Quarter 2026 results on May 14, 2026, at 8:00

a.m. (ET). To access the conference call, dial 1-888-317-6003 or 1-647-846-2809 (Passcode: 7290517#). Please

call in 15 minutes before the scheduled start time. You will be required to provide your name and organization to

the operator. You may access the webcast at <u>https://www.manulife.com/en/investors/results-and-reports</u>.

The archived webcast will be available following the call at the same URL as above. A replay of the call will also be

available until August 14, 2026, by dialing 1-855-669-9658 or 1-412-317-0088 (Passcode: 1809675#).

The First Quarter 2026 Statistical Information Package is also available on the Manulife website at <u>https://</u>

<u>w</u><u>ww.manulife.com/en/investors/results-and-reports</u>.

This earnings news release should be read in conjunction with the Company's First Quarter 2026 Report to

Shareholders, including our unaudited interim Consolidated Financial Statements for the three months ended

March 31, 2026, prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by

the International Accounting Standards Board, which is available on our website at <u>https://www.manulife.com/en/</u>

<u>investors/results-and-reports</u>. The Company's 1Q26 MD&A and additional information relating to the Company is

available on the SEDAR+ website at <u>https://www.sedarplus.ca</u> and on the U.S. Securities and Exchange

Commission's ("SEC") website at <u>https://www.sec.gov</u>.

Any information contained in, or otherwise accessible through, websites mentioned in this news release does not

form a part of this document unless it is expressly incorporated by reference.

---

| | |
|:---|:---|
| **Media Inquiries** | **Investor Relations** |
| Fiona McLean | Derek Theobalds |
| (437) 441-7491 | (416) 254-1774 |
| fiona_mclean@manulife.com | derek_theobalds@manulife.com |

---

**Earnings**

The following table presents net income attributed to shareholders, consisting of core earnings and details of the

items excluded from core earnings:

---

| | | | |
|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** |
| ($ millions) | **1Q26** | 4Q25 | 1Q25 |
| **Core earnings** |  |  |  |
| Asia | **$820** | $785 | $705 |
| Canada | **352** | 413 | 374 |
| U.S. | **331** | 319 | 361 |
| Global Wealth and Asset Management | **448** | 490 | 454 |
| Corporate and Other | **(115)** | (14) | (127) |
| **Total core earnings** | **$1836** | $1993 | $1767 |
| **Items excluded from core earnings** |  |  |  |
| Market experience gains (losses) | **(666)** | (441) | (1332) |
| Change in actuarial methods and assumptions that flow directly through income | **-** | - | - |
| Restructuring charge | **-** | (12) | - |
| Amortization of acquisition-related intangible assets<sup>(1)</sup> | **(18)** | (12) | - |
| Reinsurance transactions, tax-related items and other | **(5)** | (29) | 50 |
| **Net income attributed to shareholders**  | **$1147** | $1499 | $485 |

---

<sup>(1)</sup> Includes the amortization of intangible assets acquired in a business combination, except for amortization of software and distribution agreements. This item is

excluded from core earnings commencing in 3Q25. Prior periods have not been restated as these amounts are not considered material, and use the definition of

core earnings in effect for those periods. See our definition of core earnings in section E3 "Non-GAAP and Other Financial Measures" of the 1Q26 MD&A.

**Non-GAAP and other financial measures**

The Company prepares its Consolidated Financial Statements in accordance with IFRS as issued by the

International Accounting Standards Board. We use a number of non-GAAP and other financial measures to

evaluate overall performance and to assess each of our businesses. This section includes information required by

National Instrument 52-112 – Non-GAAP and Other Financial Measures Disclosure in respect of "specified

financial measures" (as defined therein).

**Non-GAAP financial measures** include core earnings (loss); core earnings available to common shareholders;

core earnings before interest, taxes, depreciation and amortization ("core EBITDA"); core expenses; adjusted book

value; post-tax contractual service margin; post-tax contractual service margin net of NCI ("post-tax CSM net of

NCI"); CSM net of NCI; assets under management ("AUM"); and core revenue. In addition, non-GAAP financial

measures include the following stated on a constant exchange rate ("CER") basis: any of the foregoing non-GAAP

financial measures; net income attributed to shareholders; and common shareholders' net income.

**Non-GAAP ratios** include core return on common shareholders' equity ("core ROE"); diluted core earnings per

common share ("core EPS"); expense efficiency ratio; adjusted book value per common share; financial leverage

ratio; core EBITDA margin; growth in the CSM net of NCI from organic CSM movement; and percentage growth/

decline on a constant exchange rate basis in any of the above non-GAAP financial measures and non-GAAP

ratios; net income attributed to shareholders; diluted earnings per common share ("EPS"), CSM, and new business

CSM.

**Other specified financial measures** include NBV; APE sales; gross flows; net flows; average assets under

management and administration ("average AUMA"); NBV margin; and percentage growth/decline in these

foregoing specified financial measures. In addition, explanations of the components of the CSM movement, other

than new business CSM are provided in our 1Q26 MD&A.

Non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under GAAP and,

therefore, might not be comparable to similar financial measures disclosed by other issuers. Therefore, they

should not be considered in isolation or as a substitute for any other financial information prepared in accordance

with GAAP. For more information on non-GAAP financial measures, including those referred to above, see the

section "Non-GAAP and other financial measures" in our 1Q26 MD&A, which is incorporated by reference.

**Reconciliation of core earnings to net income attributed to shareholders – 1Q26**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **1Q26** | **1Q26** | **1Q26** | **1Q26** | **1Q26** | **1Q26** |
|  | Asia | Canada | U.S. | Global WAM | Corporate<br> and Other<br>| Total  |
| Income (loss) before income taxes | **$776** | **$325** | **$159** | **$489** | **$(283)** | **$1466** |
| Income tax (expenses) recoveries |  |  |  |  |  |  |
| Core earnings | **(100)** | **(88)** | **(78)** | **(88)** | **42** | **(312)** |
| Items excluded from core earnings | **(27)** | **26** | **57** | **12** | **14** | **82** |
| Income tax (expenses) recoveries | **(127)** | **(62)** | **(21)** | **(76)** | **56** | **(230)** |
| **Net income (post-tax)** | **649** | **263** | **138** | **413** | **(227)** | **1236** |
| Less: Net income (post-tax) attributed to |  |  |  |  |  |  |
| Non-controlling interests | **33** | **-** | **-** | **10** | **-** | **43** |
| Participating policyholders | **21** | **25** | **-** | **-** | **-** | **46** |
| **Net income (loss) attributed to shareholders (post-**<br>**tax)**<br>| **595** | **238** | **138** | **403** | **(227)** | **1147** |
| Less: Items excluded from core earnings (post-tax) |  |  |  |  |  |  |
| Market experience gains (losses) | **(225)** | **(114)** | **(193)** | **(22)** | **(112)** | **(666)** |
| Changes in actuarial methods and assumptions that <br>flow directly through income<br>| **-** | **-** | **-** | **-** | **-** | **-** |
| Restructuring charge | **-** | **-** | **-** | **-** | **-** | **-** |
| Amortization of acquisition-related intangible assets | **-** | **-** | **-** | **(18)** | **-** | **(18)** |
| Reinsurance transactions, tax related items and other | **-** | **-** | **-** | **(5)** | **-** | **(5)** |
| **Core earnings (post-tax)** | **$820** | **$352** | **$331** | **$448** | **$(115)** | **$1836** |
| Income tax on core earnings (see above) | **100** | **88** | **78** | **88** | **(42)** | **312** |
| **Core earnings (pre-tax)** | **$920** | **$440** | **$409** | **$536** | **$(157)** | **$2148** |

---

**Core earnings, CER basis and U.S. dollars – 1Q26**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **1Q26** | **1Q26** | **1Q26** | **1Q26** | **1Q26** | **1Q26** |
|  | Asia | Canada | U.S. | Global WAM | Corporate<br> and Other<br>| Total  |
| **Core earnings (post-tax)** | **$820** | **$352** | **$331** | **$448** | **$(115)** | **$1836** |
| CER adjustment<sup>(1)</sup> | **-** | **-** | **-** | **-** | **-** | **-** |
| **Core earnings, CER basis (post-tax)** | **$820** | **$352** | **$331** | **$448** | **$(115)** | **$1836** |
| Income tax on core earnings, CER basis<sup>(2)</sup> | **100** | **88** | **78** | **88** | **(42)** | **312** |
| **Core earnings, CER basis (pre-tax)** | **$920** | **$440** | **$409** | **$536** | **$(157)** | **$2148** |
| **Core earnings (U.S. dollars) – Asia and U.S. segments** | **Core earnings (U.S. dollars) – Asia and U.S. segments** |  |  |  |  |  |
| **Core earnings (post-tax)**<sup>(3)</sup>**, US $** | **$598** |  | **$241** |  |  |  |
| CER adjustment US $<sup>(1)</sup> | **-** |  | **-** |  |  |  |
| **Core earnings, CER basis (post-tax), US $** | **$598** |  | **$241** |  |  |  |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

<sup>(2)</sup> Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 1Q26.

<sup>(3)</sup> Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 1Q26.

**Reconciliation of core earnings to net income attributed to shareholders – 4Q25**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 4Q25 | 4Q25 | 4Q25 | 4Q25 | 4Q25 | 4Q25 |
|  | Asia | Canada | U.S. | Global WAM | Corporate<br> and Other<br>| Total  |
| Income (loss) before income taxes | $899 | $354 | $101 | $542 | $9 | $1905 |
| Income tax (expenses) recoveries |  |  |  |  |  |  |
| Core earnings | (101) | (111) | (75) | (93) | 52 | (328) |
| Items excluded from core earnings | (102) | 25 | 55 | 10 | 30 | 18 |
| Income tax (expenses) recoveries | (203) | (86) | (20) | (83) | 82 | (310) |
| **Net income (post-tax)** | 696 | 268 | 81 | 459 | 91 | 1595 |
| Less: Net income (post-tax) attributed to |  |  |  |  |  |  |
| Non-controlling interests | 26 | - | - | 7 | - | 33 |
| Participating policyholders | 47 | 16 | - | - | - | 63 |
| **Net income (loss) attributed to shareholders (post-**<br>**tax)**<br>| 623 | 252 | 81 | 452 | 91 | 1499 |
| Less: Items excluded from core earnings (post-tax) |  |  |  |  |  |  |
| Market experience gains (losses) | (121) | (158) | (238) | (1) | 77 | (441) |
| Changes in actuarial methods and assumptions that <br>flow directly through income<br>| - | - | - | - | - | - |
| Restructuring charge | - | (3) | - | (9) | - | (12) |
| Amortization of acquisition-related intangible assets | - | - | - | (12) | - | (12) |
| Reinsurance transactions, tax related items and other | (41) | - | - | (16) | 28 | (29) |
| **Core earnings (post-tax)** | $785 | $413 | $319 | $490 | $(14) | $1993 |
| Income tax on core earnings (see above) | 101 | 111 | 75 | 93 | (52) | 328 |
| **Core earnings (pre-tax)** | $886 | $524 | $394 | $583 | $(66) | $2321 |

---

**Core earnings, CER basis and U.S. dollars – 4Q25**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 4Q25 | 4Q25 | 4Q25 | 4Q25 | 4Q25 | 4Q25 |
|  | Asia | Canada | U.S. | Global WAM | Corporate <br>and Other<br>| Total  |
| **Core earnings (post-tax)** | $785 | $413 | $319 | $490 | $(14) | $1993 |
| CER adjustment<sup>(1)</sup> | (14) | - | (6) | (6) | (1) | (27) |
| **Core earnings, CER basis (post-tax)** | $771 | $413 | $313 | $484 | $(15) | $1966 |
| Income tax on core earnings, CER basis<sup>(2)</sup> | 99 | 111 | 74 | 92 | (52) | 324 |
| **Core earnings, CER basis (pre-tax)** | $870 | $524 | $387 | $576 | $(67) | $2290 |
| **Core earnings (U.S. dollars) – Asia and U.S. segments** | **Core earnings (U.S. dollars) – Asia and U.S. segments** |  |  |  |  |  |
| **Core earnings (post-tax)**<sup>(3)</sup>**, US $** | $564 |  | $229 |  |  |  |
| CER adjustment US $<sup>(1)</sup> | (1) |  | (1) |  |  |  |
| **Core earnings, CER basis (post-tax), US $** | $563 |  | $228 |  |  |  |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

<sup>(2)</sup> Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 1Q26.

<sup>(3)</sup> Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 4Q25.

**Reconciliation of core earnings to net income attributed to shareholders – 1Q25**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 1Q25 | 1Q25 | 1Q25 | 1Q25 | 1Q25 | 1Q25 |
|  | Asia | Canada | U.S. | Global WAM | Corporate <br>and Other<br>| Total  |
| Income (loss) before income taxes | $870 | $305 | $(731) | $528 | $(273) | $699 |
| Income tax (expenses) recoveries |  |  |  |  |  |  |
| Core earnings | (101) | (89) | (84) | (86) | 29 | (331) |
| Items excluded from core earnings | (30) | 30 | 246 | 2 | 7 | 255 |
| Income tax (expenses) recoveries | (131) | (59) | 162 | (84) | 36 | (76) |
| **Net income (post-tax)** | 739 | 246 | (569) | 444 | (237) | 623 |
| Less: Net income (post-tax) attributed to |  |  |  |  |  |  |
| Non-controlling interests | 67 | - | - | 1 | (2) | 66 |
| Participating policyholders | 48 | 24 | - | - | - | 72 |
| **Net income (loss) attributed to shareholders (post-**<br>**tax)**<br>| 624 | 222 | (569) | 443 | (235) | 485 |
| Less: Items excluded from core earnings (post-tax) |  |  |  |  |  |  |
| Market experience gains (losses) | (77) | (152) | (930) | (11) | (162) | (1332) |
| Changes in actuarial methods and assumptions that <br>flow directly through income<br>| - | - | - | - | - | - |
| Restructuring charge | - | - | - | - | - | - |
| Amortization of acquisition-related intangible assets | - | - | - | - | - | - |
| Reinsurance transactions, tax related items and other | (4) | - | - | - | 54 | 50 |
| **Core earnings (post-tax)** | $705 | $374 | $361 | $454 | $(127) | $1767 |
| Income tax on core earnings (see above) | 101 | 89 | 84 | 86 | (29) | 331 |
| **Core earnings (pre-tax)** | $806 | $463 | $445 | $540 | $(156) | $2098 |

---

**Core earnings, CER basis and U.S. dollars – 1Q25**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | 1Q25 | 1Q25 | 1Q25 | 1Q25 | 1Q25 | 1Q25 |
|  | Asia | Canada | U.S. | Global WAM | Corporate <br>and Other<br>| Total  |
| **Core earnings (post-tax)** | $705 | $374 | $361 | $454 | $(127) | $1767 |
| CER adjustment<sup>(1)</sup> | (31) | - | (16) | (15) | - | (62) |
| **Core earnings, CER basis (post-tax)** | $674 | $374 | $345 | $439 | $(127) | $1705 |
| Income tax on core earnings, CER basis<sup>(2)</sup> | 96 | 89 | 80 | 84 | (28) | 321 |
| **Core earnings, CER basis (pre-tax)** | $770 | $463 | $425 | $523 | $(155) | $2026 |
| **Core earnings (U.S. dollars) – Asia and U.S. segments** | **Core earnings (U.S. dollars) – Asia and U.S. segments** |  |  |  |  |  |
| **Core earnings (post-tax)**<sup>(3)</sup>**, US $** | $492 |  | $251 |  |  |  |
| CER adjustment US $<sup>(1)</sup> | - |  | 1 |  |  |  |
| **Core earnings, CER basis (post-tax), US $** | $492 |  | $252 |  |  |  |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

<sup>(2)</sup> Income tax on core earnings adjusted to reflect the foreign exchange rates for the Statement of Income in effect for 1Q26.

<sup>(3)</sup> Core earnings (post-tax) in Canadian $ is translated to US $ using the US $ Statement of Income exchange rate for 1Q25.

**Core earnings available to common shareholders**

($ millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
| | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| Core earnings  | **$1836** | $1993 | $2035 | $1726 | $1767 | $7521 |
| Less: Preferred share dividends and other equity distributions | **58** | 103 | 58 | 103 | 57 | 321 |
| **Core earnings available to common shareholders**  | **1778** | 1890 | 1977 | 1623 | 1710 | 7200 |
| CER adjustment<sup>(1)</sup> | **-** | (27) | (16) | (21) | (62) | (126) |
| **Core earnings available to common shareholders, CER basis** | **$1778** | $1863 | $1961 | $1602 | $1648 | $7074 |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to which was used in 1Q26.

**Core ROE**

($ millions, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
| | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| Core earnings available to common shareholders | **$1778** | $1890 | $1977 | $1623 | $1710 | $7200 |
| **Annualized core earnings available to common shareholders (post-tax)** | **$7211** | $7498 | $7844 | $6510 | $6935 | $7200 |
| **Average common shareholders' equity (see below)** | **$43717** | $43759 | $43238 | $43448 | $44394 | $43709 |
| **Core ROE (annualized) (%)** | **16.5%** | 17.1% | 18.1% | 15.0% | 15.6% | 16.5% |
| **Average common shareholders' equity** |  |  |  |  |  |  |
| Total shareholders' and other equity | **$50632** | $50121 | $50716 | $49080 | $51135 | $50121 |
| Less: Preferred shares and other equity | **6660** | 6660 | 6660 | 6660 | 6660 | 6660 |
| Common shareholders' equity | **$43972** | $43461 | $44056 | $42420 | $44475 | $43461 |
| **Average common shareholders' equity** | **$43717** | $43759 | $43238 | $43448 | $44394 | $43709 |

---

**CSM and post-tax CSM information**

($ millions pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **As at**  | **Mar 31, 2026** | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| CSM | **$27325** | $26568 | $26283 | $23722 | $23713 |
| Less: CSM for NCI | **1736** | 1599 | 1565 | 1406 | 1417 |
| **CSM, net of NCI** | **$25589** | $24969 | $24718 | $22316 | $22296 |
| CER adjustment<sup>(1)</sup> | **-** | 332 | (66) | 197 | (556) |
| **CSM, net of NCI, CER basis** | **$25589** | $25301 | $24652 | $22513 | $21740 |
| **CSM by segment** |  |  |  |  |  |
| Asia | **$18228** | $17750 | $17580 | $15786 | $15904 |
| Asia NCI | **1736** | 1599 | 1565 | 1406 | 1417 |
| Canada | **4432** | 4459 | 4490 | 4133 | 4052 |
| U.S. | **2927** | 2760 | 2649 | 2386 | 2329 |
| Corporate and Other | **2** | - | (1) | 11 | 11 |
| **CSM** | **$27325** | $26568 | $26283 | $23722 | $23713 |
| **CSM, CER adjustment**<sup>(1)</sup> |  |  |  |  |  |
| Asia | **$-** | $282 | $(74) | $143 | $(486) |
| Asia NCI | **-** | 46 | 50 | 80 | 23 |
| Canada | **-** | - | - | - | - |
| U.S. | **-** | 50 | 8 | 54 | (70) |
| Corporate and Other | **-** | - | - | 1 | - |
| **Total** | **$-** | $378 | $(16) | $278 | $(533) |
| **CSM, CER basis** |  |  |  |  |  |
| Asia | **$18228** | $18032 | $17506 | $15929 | $15418 |
| Asia NCI | **1736** | 1645 | 1615 | 1486 | 1440 |
| Canada | **4432** | 4459 | 4490 | 4133 | 4052 |
| U.S. | **2927** | 2810 | 2657 | 2440 | 2259 |
| Corporate and Other | **2** | - | (1) | 12 | 11 |
| **Total CSM, CER basis** | **$27325** | $26946 | $26267 | $24000 | $23180 |
| **Post-tax CSM** |  |  |  |  |  |
| CSM | **$27325** | $26568 | $26283 | $23722 | $23713 |
| Marginal tax rate on CSM | **(4510)** | (4403) | (4347) | (3940) | (3929) |
| **Post-tax CSM** | **$22815** | $22165 | $21936 | $19782 | $19784 |
| CSM, net of NCI | **$25589** | $24969 | $24718 | $22316 | $22296 |
| Marginal tax rate on CSM net of NCI | **(4334)** | (4236) | (4181) | (3789) | (3772) |
| **Post-tax CSM net of NCI** | **$21255** | $20733 | $20537 | $18527 | $18524 |

---

<sup>(1)</sup> The impact of reflecting CSM and CSM net of NCI using the foreign exchange rates for the Statement of Financial Position in effect for 1Q26.

**New business CSM**<sup>(1)</sup> **detail, CER basis**

($ millions pre-tax, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
|  | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| **New business CSM** |  |  |  |  |  |  |
| Hong Kong | **$316** | $244 | $287 | $286 | $316 | $1133 |
| Japan | **167** | 159 | 76 | 74 | 81 | 390 |
| Mainland China | **114** | 55 | 112 | 63 | 126 | 356 |
| Singapore | **165** | 159 | 182 | 140 | 138 | 619 |
| Other<sup>(2)</sup> | **40** | 80 | 55 | 100 | 54 | 289 |
| Asia | **802** | 697 | 712 | 663 | 715 | 2787 |
| Canada | **103** | 135 | 109 | 100 | 91 | 435 |
| U.S. | **114** | 188 | 145 | 119 | 101 | 553 |
| Total new business CSM | **$1019** | $1020 | $966 | $882 | $907 | $3775 |
| **New business CSM, CER adjustment**<sup>(3)</sup> |  |  |  |  |  |  |
| Hong Kong | **$-** | $(4) | $(1) | $(2) | $(13) | $(20) |
| Japan | **-** | (6) | (5) | (6) | (6) | (23) |
| Mainland China | **-** | 1 | 3 | 2 | - | 6 |
| Singapore | **-** | (1) | 1 | 1 | 1 | 2 |
| Other<sup>(2)</sup> | **-** | (1) | (1) | (1) | (2) | (5) |
| Asia | **-** | (11) | (3) | (6) | (20) | (40) |
| Canada | **-** | - | - | - | - | - |
| U.S. | **-** | (4) | (1) | (1) | (4) | (10) |
| Total new business CSM | **$-** | $(15) | $(4) | $(7) | $(24) | $(50) |
| **New business CSM, CER basis** |  |  |  |  |  |  |
| Hong Kong | **$316** | $240 | $286 | $284 | $303 | $1113 |
| Japan | **167** | 153 | 71 | 68 | 75 | 367 |
| Mainland China | **114** | 56 | 115 | 65 | 126 | 362 |
| Singapore | **165** | 158 | 183 | 141 | 139 | 621 |
| Other<sup>(2)</sup> | **40** | 79 | 54 | 99 | 52 | 284 |
| Asia | **802** | 686 | 709 | 657 | 695 | 2747 |
| Canada | **103** | 135 | 109 | 100 | 91 | 435 |
| U.S. | **114** | 184 | 144 | 118 | 97 | 543 |
| **Total new business CSM, CER basis** | **$1019** | $1005 | $962 | $875 | $883 | $3725 |

---

<sup>(1)</sup> New business CSM is net of NCI.

<sup>(2)</sup> Other includes Cambodia, Indonesia, International High Net Worth, Malaysia, Myanmar, the Philippines and Vietnam.

<sup>(3)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

**Net income financial measures on a CER basis**

($ Canadian millions, post-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
|  | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| **Net income (loss) attributed to shareholders:** |  |  |  |  |  |  |
| Asia | **$595** | $623 | $895 | $830 | $624 | $2972 |
| Canada | **238** | 252 | 449 | 390 | 222 | 1313 |
| U.S. | **138** | 81 | (75) | 36 | (569) | (527) |
| Global WAM | **403** | 452 | 523 | 482 | 443 | 1900 |
| Corporate and Other | **(227)** | 91 | 7 | 51 | (235) | (86) |
| **Total net income (loss) attributed to shareholders** | **1147** | 1499 | 1799 | 1789 | 485 | 5572 |
| Preferred share dividends and other equity distributions | **(58)** | (103) | (58) | (103) | (57) | (321) |
| **Common shareholders' net income (loss)** | **$1089** | $1396 | $1741 | $1686 | $428 | $5251 |
| CER adjustment<sup>(1)</sup> |  |  |  |  |  |  |
| Asia | **$-** | $(6) | $9 | $(8) | $(40) | $(45) |
| Canada | **-** | (1) | 2 | (1) | 2 | 2 |
| U.S. | **-** | (1) | (2) | - | 24 | 21 |
| Global WAM | **-** | (8) | (1) | (5) | (20) | (34) |
| Corporate and Other | **-** | (3) | (2) | 3 | 9 | 7 |
| **Total net income (loss) attributed to shareholders**  | **-** | (19) | 6 | (11) | (25) | (49) |
| Preferred share dividends and other equity distributions  | **-** | - | - | - | - | - |
| **Common shareholders' net income (loss)** | **$-** | $(19) | $6 | $(11) | $(25) | $(49) |
| Net income (loss) attributed to shareholders, CER basis |  |  |  |  |  |  |
| Asia | **$595** | $617 | $904 | $822 | $584 | $2927 |
| Canada | **238** | 251 | 451 | 389 | 224 | 1315 |
| U.S. | **138** | 80 | (77) | 36 | (545) | (506) |
| Global WAM | **403** | 444 | 522 | 477 | 423 | 1866 |
| Corporate and Other | **(227)** | 88 | 5 | 54 | (226) | (79) |
| **Total net income (loss) attributed to shareholders, CER basis** | **1147** | 1480 | 1805 | 1778 | 460 | 5523 |
| Preferred share dividends and other equity distributions, CER basis | **(58)** | (103) | (58) | (103) | (57) | (321) |
| **Common shareholders' net income (loss), CER basis** | **$1089** | $1377 | $1747 | $1675 | $403 | $5202 |
| Asia net income attributed to shareholders, U.S. dollars |  |  |  |  |  |  |
| Asia net income (loss) attributed to shareholders, US $<sup>(2)</sup> | **$433** | $447 | $649 | $600 | $435 | $2131 |
| CER adjustment, US $<sup>(1)</sup> | **-** | 3 | 10 | (1) | (9) | 3 |
| **Asia net income (loss) attributed to shareholders, U.S. $, CER basis**<sup>(1)</sup> | **$433** | $450 | $659 | $599 | $426 | $2134 |
| Net income (loss) attributed to shareholders (pre-tax) |  |  |  |  |  |  |
| Net income (loss) attributed to shareholders (post-tax) | **$1147** | $1499 | $1799 | $1789 | $485 | $5572 |
| Tax on net income attributed to shareholders | **215** | 292 | 283 | 307 | 47 | 929 |
| **Net income (loss) attributed to shareholders (pre-tax)** | **1362** | 1791 | 2082 | 2096 | 532 | 6501 |
| CER adjustment<sup>(1)</sup> | **-** | (17) | (20) | (23) | (18) | (78) |
| **Net income (loss) attributed to shareholders (pre-tax), CER basis** | **$1362** | $1774 | $2062 | $2073 | $514 | $6423 |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

<sup>(2)</sup> Asia net income attributed to shareholders (post-tax) in Canadian dollars is translated to U.S. dollars using the U.S. dollar Statement of Income rate for the

reporting period.

**Adjusted book value**

($ millions)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Mar 31, 2026** | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| **As at** | **Mar 31, 2026** | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Common shareholders' equity | **$43972** | $43461 | $44056 | $42420 | $44475 |
| Post-tax CSM, net of NCI | **21255** | 20733 | 20537 | 18527 | 18524 |
| **Adjusted book value** | **$65227** | $64194 | $64593 | $60947 | $62999 |

---

**Reconciliation of Global WAM core earnings to core EBITDA**

($ millions, pre-tax and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
|  | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| **Global WAM core earnings (post-tax)**  | **$448** | $490 | $525 | $463 | $454 | $1932 |
| Add back taxes, acquisition costs, other expenses and deferred sales <br>commissions<br>|  |  |  |  |  |  |
| Core income tax (expenses) recoveries (see above) | **88** | 93 | 82 | 89 | 86 | 350 |
| Amortization of deferred acquisition costs and other depreciation | **63** | 61 | 44 | 51 | 46 | 202 |
| Amortization of deferred sales commissions | **24** | 24 | 21 | 20 | 22 | 87 |
| **Core EBITDA** | **$623** | $668 | $672 | $623 | $608 | $2571 |
| CER adjustment<sup>(1)</sup> | **-** | (9) | (2) | (5) | (20) | (36) |
| **Core EBITDA, CER basis** | **$623** | $659 | $670 | $618 | $588 | $2535 |

---

<sup>(1)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

**Core EBITDA margin and core revenue**

($ millions, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
|  | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| **Core EBITDA margin** |  |  |  |  |  |  |
| Core EBITDA | **$623** | $668 | $672 | $623 | $608 | $2571 |
| Core revenue | **$2146** | $2285 | $2175 | $2069 | $2140 | $8669 |
| **Core EBITDA margin** | **29.0%** | 29.2% | 30.9% | 30.1% | 28.4% | 29.7% |
| **Global WAM core revenue** |  |  |  |  |  |  |
| Other revenue per financial statements | **$1930** | $2147 | $2145 | $1851 | $1986 | $8129 |
| Less: Other revenue in segments other than Global WAM | **(56)** | 28 | 121 | (53) | 11 | 107 |
| **Other revenue in Global WAM (fee income)** | **$1986** | $2119 | $2024 | $1904 | $1975 | $8022 |
| Investment income per financial statements | **$4536** | $5358 | $4682 | $4740 | $4234 | $19014 |
| Realized and unrealized gains (losses) on assets supporting insurance and <br>investment contract liabilities per financial statements<br>| **(1384)** | 1106 | 3784 | 2377 | (992) | 6275 |
| Total investment income  | **3152** | 6464 | 8466 | 7117 | 3242 | 25289 |
| Less: Investment income in segments other than Global WAM | **3015** | 6300 | 8275 | 6924 | 3089 | 24588 |
| Investment income in Global WAM | **$137** | $164 | $191 | $193 | $153 | $701 |
| Total other revenue and investment income in Global WAM | **$2123** | $2283 | $2215 | $2097 | $2128 | $8723 |
| Less: Total revenue reported in items excluded from core earnings |  |  |  |  |  |  |
| Market experience gains (losses) | **(28)** | (1) | 24 | 20 | (14) | 29 |
| Revenue related to integration and acquisitions | **5** | (1) | 16 | 8 | 2 | 25 |
| **Global WAM core revenue** | **$2146** | $2285 | $2175 | $2069 | $2140 | $8669 |

---

**Core expenses**

($ millions, and based on actual foreign exchange rates in effect in the applicable reporting period, unless otherwise stated)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Quarterly Results** | **Full Year** <br>**Results**<br>|
|  | **1Q26** | 4Q25 | 3Q25 | 2Q25 | 1Q25 | 2025 |
| **Core expenses** |  |  |  |  |  |  |
| General expenses – Statements of Income | **$1251** | $1327 | $1232 | $1140 | $1202 | $4901 |
| Directly attributable acquisition expense for contracts measured using the PAA <br>method and products without a CSM<sup>(1)</sup><br>| **48** | 48 | 42 | 40 | 42 | 172 |
| Directly attributable maintenance expense<sup>(1)</sup> | **552** | 542 | 524 | 514 | 532 | 2112 |
| Total expenses | **1851** | 1917 | 1798 | 1694 | 1776 | 7185 |
| Less: General expenses included in items excluded from core earnings |  |  |  |  |  |  |
| Restructuring charge | **-** | 16 | - | - | - | 16 |
| Amortization of acquisition-related intangible assets | **23** | 16 | 8 | - | - | 24 |
| Integration and acquisition | **-** | 7 | 22 | - | - | 29 |
| Legal provisions and Other expenses | **1** | 5 | 10 | 5 | - | 20 |
| Total | **24** | 44 | 40 | 5 | - | 89 |
| **Core expenses** | **$1827** | $1873 | $1758 | $1689 | $1776 | $7096 |
| CER adjustment<sup>(2)</sup> | **-** | (18) | (5) | (12) | (39) | (74) |
| **Core expenses, CER basis** | **$1827** | $1855 | $1753 | $1677 | $1737 | $7022 |
| Total expenses | **$1851** | $1917 | $1798 | $1694 | $1776 | $7185 |
| CER adjustment<sup>(2)</sup> | **-** | (18) | (5) | (11) | (40) | (74) |
| **Total expenses, CER basis** | **$1851** | $1899 | $1793 | $1683 | $1736 | $7111 |

---

<sup>(1)</sup> Expenses are components of insurance service expenses on the Statements of Income that flow directly through income.

<sup>(2)</sup> The impact of updating foreign exchange rates to that which was used in 1Q26.

**CAUTION REGARDING FORWARD-LOOKING STATEMENTS**

From time to time, Manulife makes written and/or oral forward-looking statements, including in this document. In addition,

our representatives may make forward-looking statements orally to analysts, investors, the media and others. All such

statements are made pursuant to the "safe harbour" provisions of Canadian provincial securities laws and the U.S.

Private Securities Litigation Reform Act of 1995.

The forward-looking statements in this document include, but are not limited to, statements with respect to our ability to

achieve our medium-term financial and operating targets, the anticipated benefits of the acquisition of Schroders

Indonesia and the partnership between Global WAM and L&G, the expected benefits and value derived from the use of

AI and also relate to, among other things, our objectives, goals, strategies, intentions, plans, beliefs, expectations and

estimates, and can generally be identified by the use of words such as "may", "will", "could", "should", "would", "likely",

"suspect", "outlook", "expect", "intend", "estimate", "anticipate", "believe", "plan", "forecast", "objective", "seek", "aim",

"continue", "goal", "restore", "embark" and "endeavour" (or the negative thereof) and words and expressions of similar

import, and include statements concerning possible or assumed future results. Although we believe that the expectations

reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue

reliance should not be placed on such statements and they should not be interpreted as confirming market or analysts'

expectations in any way.

Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ

materially from those expressed or implied in such statements.

Important factors that could cause actual results to differ materially from expectations include but are not limited to:

general business and economic conditions (including but not limited to the performance, volatility and correlation of equity

markets, interest rates, credit and swap spreads, inflation rates, currency rates, investment losses and defaults, market

liquidity and creditworthiness of guarantors, reinsurers and counterparties); changes in laws and regulations; changes in

accounting standards applicable in any of the territories in which we operate; changes in regulatory capital requirements;

our ability to obtain premium rate increases on in-force policies; our ability to execute strategic plans and changes to

strategic plans; downgrades in our financial strength or credit ratings; our ability to maintain our reputation; impairments of

goodwill or intangible assets or the establishment of provisions against future tax assets; the accuracy of estimates

relating to morbidity, mortality and policyholder behaviour; the accuracy of other estimates used in applying accounting

policies and actuarial methods and embedded value methods; our ability to implement effective hedging strategies and

unforeseen consequences arising from such strategies; our ability to source appropriate assets to back our long-dated

liabilities; level of competition and consolidation; our ability to market and distribute products through current and future

distribution channels; unforeseen liabilities or asset impairments arising from acquisitions and dispositions of businesses;

the realization of losses arising from the sale of investments classified fair value through other comprehensive income;

our liquidity, including the availability of financing to satisfy existing financial liabilities on expected maturity dates when

required; obligations to pledge additional collateral; the availability of letters of credit to provide capital management

flexibility; accuracy of information received from counterparties and the ability of counterparties to meet their obligations;

the availability, affordability and adequacy of reinsurance; legal and regulatory proceedings, including tax audits, tax

litigation or similar proceedings; our ability to adapt products and services to the changing market; our ability to attract and

retain key executives, employees and agents; the appropriate use and interpretation of complex models or deficiencies in

models used; political, legal, operational and other risks associated with our operations; geopolitical uncertainty, including

international conflicts and trade disputes; acquisitions and our ability to complete acquisitions including the availability of

equity and debt financing for this purpose; the disruption of or changes to key elements of the Company's or public

infrastructure systems; environmental concerns, including climate change; our ability to protect our intellectual property

and exposure to claims of infringement; our ability to execute our digital plans and to deploy future digital use cases,

including with respect to AI, the anticipated benefits from the Schroders Indonesia acquisition and the partnership

between Global WAM and L&G, and our inability to withdraw cash from subsidiaries.

Additional information about material risk factors that could cause actual results to differ materially from expectations and

about material factors or assumptions applied in making forward-looking statements may be found under "Risk

Management and Risk Factors" and "Critical Actuarial and Accounting Policies" in the Management's Discussion and

Analysis in our most recent annual report, under "Risk Management and Risk Factors Update" and "Critical Actuarial and

Accounting Policies" in the Management's Discussion and Analysis in our most recent interim report, and in the "Risk

Management" note to the Consolidated Financial Statements in our most recent annual and interim reports, as well as

elsewhere in our filings with Canadian and U.S. securities regulators.

The forward-looking statements in this document are, unless otherwise indicated, stated as of the date hereof and are

presented for the purpose of assisting investors and others in understanding our financial position and results of

operations, our future operations, as well as our objectives and strategic priorities, and may not be appropriate for other

purposes. We do not undertake to update any forward-looking statements, except as required by law.

## Exhibit 99.2

**Exhibit 99.2**

![picture1.jpg](picture1.jpg)

**News**

**Release**

C$ unless otherwise statedTSX/NYSE/PSE: MFC SEHK: 945

For Immediate Release

May 13, 2026

**Manulife declares common share dividend** 

**Toronto** - Manulife's Board of Directors today announced a quarterly common shareholders' dividend of

$0.485 per share on the common shares of Manulife, payable on and after June 19, 2026, to

shareholders of record at the close of business on May 29, 2026.

In respect of the Company's Canadian Dividend Reinvestment and Share Purchase Plan and its U.S.

Dividend Reinvestment and Share Purchase Plan, the Company will purchase common shares on the

open market in connection with the reinvestment of dividends and optional cash purchases under these

plans. The purchase price of these common shares will be based on the average of the actual cost to

purchase them and there are no applicable discounts.

**About Manulife**

Manulife Financial Corporation is a leading international financial services provider, headquartered in

Toronto, Canada. Anchored in our ambition to be the number one choice for customers, we operate as

Manulife across Canada and Asia, and primarily as John Hancock in the United States, providing financial

advice, insurance and health solutions for individuals, groups and businesses. Through Manulife Wealth &

Asset Management, we offer global investment solutions, financial advice, and retirement plan services to

individuals, institutions, and retirement plan members worldwide. At the end of 2025, we had more than

37,000 employees, over 106,000 agents, and thousands of distribution partners, serving over 37 million

customers with operations across 25 markets globally. We trade as 'MFC' on the Toronto, New York, and

Philippine stock exchanges, and under '945' in Hong Kong stock exchange. Not all offerings are available

in all jurisdictions. For additional information, please visit <u>manulife.com</u>.

**Media ContactInvestor Relations**

Fiona McLeanDerek Theobalds

ManulifeManulife

437-441-7491416-254-1774

<u>fiona_mclean@manulife.com</u><u>derek_theobalds@manulife.com</u>